Psychopharmacology of Violence: Part II: Beyond the Acute Episode
1997; Slack Incorporated (United States); Volume: 27; Issue: 10 Linguagem: Inglês
10.3928/0048-5713-19971001-11
ISSN1938-2456
Autores Tópico(s)Schizophrenia research and treatment
ResumoVIOLENT BEHAVIORPsychopharmacology of Violence: Part II: Beyond the Acute Episode Leslie Citrome, MD, MPH, , and , MD, MPH Jan Volavka, MD, PhD, , MD, PhD Leslie Citrome, MD, MPH and Jan Volavka, MD, PhD Published Online:October 01, 1997https://doi.org/10.3928/0048-5713-19971001-11PDFView Full Text ToolsAdd to favoritesDownload CitationsTrack Citations ShareShare onFacebookTwitterLinkedInRedditEmail SectionsMore1. Volavka J. Neurobiology of Violence. Washington, DC: American Psychiatric Press, Ine; 1995. Google Scholar2. Krakowski MI, Kunz M, Czobor P, Volavka J. Long-term high-dose neuroleptic treatment: who gets it and why? Hosp Community Psychiatry. 1993; 44:640-644. Google Scholar3. Apter A, Van Praag HM, Plutchik R, Sevy S, Korn M, Brown SL. Interrelationships among anxiety, aggression, impulsivity, and mood: a serotonergically linked cluster? Psychiatr Res. 1990; 32:191-199. Google Scholar4. Roy A, Linnoila M. Suicidal behavior, impulsiveness and serotonin. Acta Psychiatr Scand. 1988; 78:529-535. Google Scholar5. Virkkunen M, Goldman D, Nielsen DA, Linnoila M. Low brain serotonin turnover rate (low CSF 5-HIAA) and impulsive violence. J Psychiatry Neurosci. 1995; 20:271275. Google Scholar6. Linnoila M, Virkkunen M, Scheinin M, Nuutila A, Rimon R, Goodwin FK. Low cerebrospinal fluid 5-hydroxyindole acetic acid concentration differentiates impulsive from non-impulsive violent behavior. Life Sci. 1983; 33:26092614. Google Scholar7. Virkkunen M, Linnoila M. Serotonin in early onset, male alcoholics with violent behavior. Ann Med. 1990; 22:327331. Google Scholar8. Virkkunen M, De Jong J, Bartko J, Linnoila M. Psychobiological concomitants of history of suicide attempts among violent offendere and impulsive fire setters. Arch Gen Psychiatry. 1989; 46:604-606. Google Scholar9. Coccaro EF, Siever LJ, Klar HM, et al. Serotonergic studies in patients with affective and personality disorders. Arch Gen Psychiatry. 1989; 46:587-599. Google Scholar10. Wilson WH, Claussen AM. 18-month outcome of clozapine treatment for 100 patients in a state psychiatric hospital. Psychiatr Serv. 1995; 46:386-389. Google Scholar1 1 . Ratey JJ, Leveroni C, Kilmer D, Gutheil C, Swartz B. The effects of clozapine on severely aggressive psychiatric inpatients in a state hospital. J Clin Psychiatry. 1993; 54:219-223. Google Scholar12. Michals ML, Crisroon ML, Roberts S, et al. Clozapine response and adverse effects in nine brain-injured patients. J Clin Psychopharmacol. 1993; 13:198-203. Google Scholar13. Volavka J, Zito JM, Vitrai J, Czobor P. Clozapine effects on hostility and aggression in schizophrenia. J Clin Psychopharmacol. 1993; 13:287-289. Google Scholar14. Chiles JA, Davidson P, McBride D. Effects of clozapine on use of seclusion and restraint at a state hospital. Hosp Community Psychiatry. 1994; 45:269-271. Google Scholar15. Czobor P, Volavka J, Meibach RC. Effect of risperidone on hostility in schizophrenia. J Clin Psychopharmacol. 1995; 15:243-249. Google Scholar16. Marder SR, Meibach RC. Risperidone in the treatment of schizophrenia. Am J Psychiatry. 1994; 151:825-835. Google Scholar17. Williams DT, Mehl R, Yudofsky S, et al. The effect of propranolol on uncontrolled rage outbursts in children and adolescents with organic brain dysfunction. Am Acad Child Psychiatry. 1982; 21:129-135. Google Scholar18. Pétrie WM, Ban TA. Propranolol in organic agitation. Lancet. 1981; 1:324. Letter. Google Scholar19. Ratey JJ, Mikkelsen EJ, Smith GB, et al. Beta-blockers in the severely and profoundly mentally retarded. J Clin Psychopharmacol. 1986; 6:103-107. Google Scholar20. Ratey JJ, Morrill R, Oxenkrug G. Use of propranolol for provoked and unprovoked episodes of rage. Am J Psychiatry. 1983; 140:1356-1357. Google Scholar21. Ratey JJ, Mikkelsen E, Sorgi P, et al. Autism: the treatment of aggressive behaviors. J Clin Psychopharmacol. 1987; 7:35-41. Google Scholar22. Elliott FA. Propranolol for the control of belligerent behavior following acute brain damage. Ann Neurol. 1977;1:489-491. Google Scholar23. Yudofsky S, Williams D, Gorman J. Propranolol in the treatment of rage and violent behavior in patients with chronic brain syndrome. Am J Psychiatry. 1981; 138:218220. Google Scholar24. Mansheim P. Treatment with propranolol of the behavioral sequelae of brain damage. J Clin Psychiatry. 1981; 42:132. Letter. Google Scholar25. Yudofsky SC, Stevens L, Silver JM, Barsa J, Williams D. Propranolol in the treatment of rage and violent behavior associated with Korsakoff's psychosis. Am J Psychiatry. 1984; 141:114-115. Google Scholar26. Greendyke RM, Kanter DR, Schuster DB, et al. Propranolol treatment of assaultive patients with organic brain disease. J Nerv Ment Dis. 1986; 174:290-294. Google Scholar27. Stewart JT, Mounts ML, Clark RL Jr. Aggressive behavior in Huntington's disease: treatment with propranolol. J Clin Psychiatry. 1987; 48:106-108. Google Scholar28. Schreier HA. Use of propranolol in the treatment of postencephalitic psychosis. Am J Psychiatry. 1979; 156:840-841. Google Scholar29. Yudofsky SC, Silver JM, Hales RE. Pharmacologic management of aggression in the elderly. J Clin Psychiatry. 1990; 51(supplj:22-28. Google Scholar30. Sheppard GP. High-dose propranolol in schizophrenia. Br J Psychiatry. 1979; 134:470-476. Google Scholar31. Sorgi PJ, Ratey JJ, Polakoff S. Beta-adrenergic blockers for the control of aggressive behaviors in patients with chronic schizophrenia. Am J Psychiatry. 1986; 143:775776. Google Scholar32. Ratey JJ, Sorgi P, O'Driscoll GA, et al. Nadolol to treat aggression and psychiatric symptomatology in chronic psychiatric inpatients: a double-blind, placebo-controlled study. J Clin Psychiatry. 1992; 53:41-46. Google Scholar33. Alpert M, Allan ER, Citrome L, Laury G, Sison C, Sudilovsky A. A double-blind, placebo-controlled study of adjunctive nadolol in the management of violent psychiatric patients. Psychopharmacol Bull. 1990; 26:367-371. Google Scholar34. Polakoff SA, Sorgi PJ, Ratey JJ The treatment of impulsive and aggressive behavior with nadolol. J Clin Psychopharmacol. 1986; 6:125-126. Letter. Google Scholar35. Mattes JA. Metoprolol for intermittent explosive disorder. Am J Psychiatry. 1985; 142:1108-1109. Google Scholar36. Kastner T, Burlingham K, Friedman DL. Metoprolol for aggressive behavior in persons with mental retardation. Am Fam Physician. 1990; 42:1585-1588. Google Scholar37. Greendyke RM, Kanter DR. Therapeutic effects of pindolol on behavioral disturbances associated with organic brain disease: a double-blind study. J Clin Psychiatry. 1986; 47:423-426. Google Scholar38. Citrome L. Use of lithium, carbamazepine, and valproic acid in a state-operated psychiatric hospital. Journal of Pharmacy Technology. 1995; 11:55-59. Google Scholar39. Yesavage JA. Bipolar illness: correlates of dangerous inpatient behavior. Br J Psychiatry. 1983; 143:554-557. Google Scholar40. Dostal T, Zvolsky P. Antiaggressive effect of lithium salts in severe mentally retarded adolescents. International Pharmacopsychiatry. 1970; 5:203-207. Google Scholar41. Tyrer SP, Walsh A, Edwards DE, et al. Factors associated with a good response to lithium in aggressive mentally handicapped subjects. Prog Neuropsyckopharmacol Biol Psychiatry. 1984; 8:751-755. Google Scholar42. Spreat S, Behar D, Reneski B, et al. Lithium carbonate for aggression in mentally retarded persons. Compr Psychiatry. 1989; 30:505-511. Google Scholar43. Craft M, Ismail IA, Krishnamurti D, et al. Lithium in the treatment of aggression in mentally handicapped patients. A double-blind trial. Br J Psychiatry. 1987; 150:685-689. Google Scholar44. Luchins DJ, Dojka D. Lithium and propranolol in aggression and self-injurious behavior in the mentally retarded. Psychopharmacol Bull. 1989; 25:372-375. Google Scholar45. Haas JF, Cope DN. Neuropharmacology management of behavior sequelae in head injury: a case report. Arch Phys Med Rehabil. 1985; 66:472-474. Google Scholar46. Hornstein A, Seliger G. Cognitive side effects of lithium in closed head injury. J Neuropsychiatry. 1989; 1:446-447. Google Scholar47. Sheard MH. Effect of lithium on human aggression. Nature. 1971; 230:113-114. Google Scholar48. Tupín JP, Smith DB, Clanon TL, et al. The long-term use of lithium in aggressive prisoners. Compr Psychiatry. 1973; 14:311-317. Google Scholar49. Sheard MH, Marini JL, Bridges CI, et al. The effect of lithium on impulsive aggressive behavior in man. Am J Psychiatry. 1976; 133:1409-1413. Google Scholar50. Schiff HB, Sabin TD, Geller A, et al. Lithium in aggressive behavior. Am J Psychiatry. 1982; Google Scholar51. Hakola HP, Laulumaa VA. Carbamazepine in treatment of violent schizophrenics. Lancet. 1982; 1:1358. Letter. Google Scholar52. Luchins DJ. Carbamazepine in violent non-epileptic schizophrenics. Psychopharmacol Bull. 1984; 20:569-571. Google Scholar53. Mattes JA. Carbamazepine for uncontrolled rage outbursts. Lancet. 1984; 2:1164-1165. Google Scholar54. Okuma T, Yamashita I, Takahashi R, et al. A double-blind study of adjunctive carbamazepine versus placebo on excited states of schizophrenic and schizoaffective disorders. Acta Psychiatr Scand. 1989; 80:250-259. Google Scholar55. Neppe VM. Carbamazepine as adjunctive treatment in nonepileptic chronic inpatients with EEG temporal lobe abnormalities. J Clin Psychiatry. 1983; 44:326-331. Google Scholar56. Neppe VM. Carbamazepine in nonresponsive psychosis. J Clin Psychiatry. 1988; 49(suppl):22-28. Google Scholar57. Simhandl C, Meszaros K. The use of carbamazepine in the treatment of schizophrenic and schizoaffective psychoses: a review. J Psychiatry Clin Neurosci. 1992; 17:114. Google Scholar58. Young JL, Hillbrand M. Carbamazepine lowers aggression: a review. BuIlAm Acad Psychiatry Law. 1994; 22:53 Google Scholar59. Wassef A, Watson D, Morrison P, Bryant S, Flack J. Neuroleptic-valproic acid combination in treatment of psychotic symptoms: a three-case report. J Clin Psychopharmacol. 1989; Google Scholar60. Morinigo A, Martin J, Gonzalez S, Mateo I. Treatment of resistant schizophrenia with valproate and neuroleptic drugs. J Clin Psychiatry. 1989; Google Scholar61. Alam MY, KLass DB, Luchins DJ, Aleem Y, Enich G. Effectiveness of divalproex sodium, valproic acid and carbamazepine in aggression (poster). NCDEU 35th Annual Meeting; Orlando, FIa; 1995. Google Scholar62. Wilcox J. Divalproex sodium in the treatment of aggressive behavior. Aran Clin Psychiatry. 1994; 6:17-20. Google Scholar63. Keats MM, Mukherjee S. Antiaggressive effect of adjunctive clonazepam in schizophrenia associated with seizure disorder. J Clin Psychiatry. 1988; 49:117-118. Google Scholar64. Karson CN, Weinberger DR, Bigelow L, Wyatt RJ. Clonazepam treatment of chronic schizophrenia: negative results in a double-blind, placebo-controlled trial. Am J Psychiatry. 1982; 139:1627-1628. Google Scholar65. Jackson RD, Corrigan JD, Arnett JA. Amitriptyline for agitation in head injury. ArcA Phys Med Rehabil. 1985; 66:180-181. Google Scholar66. Mysiw WJ, Jackson RD, Corrigan JD. Amitriptyline for post-traumatic agitation. Am J Pkys Med Rehabil. 1988; Google Scholar67. Simpson DM, Foster D. Improvement in organically disturbed behavior with trazodone treatment. J Clin Psychiatry. 1986; Google Scholar68. Pinner E, Rich CL. Effects of trazodone on aggressive behavior in seven patients with organic mental disorders. Am J Psychiatry. 1988; Google Scholar69. O'Neil M, Page N, Adkins WN, et al. Tryptophantrazodone treatment of aggressive behavior. Lancet. 1986; 2:859-860. Google Scholar70. Greenwald BS, Marin DB, Silverman SM. Serotonergic treatment of screaming and banging in dementia. Lancet. 1986; 2:1464-1465. Letter. Google Scholar71. Wilcock GK, Stevens J, Perkins A. Trazodone/tryptophan for aggressive behavior. Lancet. 1987; 1:929-930. Letter. Google Scholar72. Gedye A Serotonergic treatment for aggression in a Down's syndrome adult showing signs of Alzheimer's disease. Journal of Mental Deficiency Research. 1991; 35:247-258. Google Scholar73. Coccaro EF, Astili JL, Herbert JL, et al. Fluoxetine treatment of impulsive aggression in DSM-III-R personality disorder patients. J Clin Psychopharmacol. 1990; 10:373375. Letter. Google Scholar74. Goldman MB, Janecek HM. Adjunctive fluoxetine improves global function in chronic schizophrenia. J Neuropsychiatr Clin Neurosci. 1990; 2:429-431. Google Scholar75. Fava M, Rosenbaum JF, Pava JA, et al. Anger attacks in unipolar depression, part 1: clinical correlates and response to fluoxetine treatment. Am J Psychiatry. 1993; 150:1158-1163. Google Scholar76. Markowitz PI. Effect of fluoxetine on self-injurious behavior in the developmentally disabled: a preliminary study. J Clin Psychopharmacol. 1992; 12:27-31. Google Scholar77. Cornelius JR, Soloff PH, Perei JM, Ulrich RF. Fluoxetine trial in borderline personality disorder. Psychopharmacol Bull. 1990; 26:151-154. Google Scholar78. Cornelius JR, Soloff PH, Perei JM, Ulrich RF. A preliminary trial of fluoxetine in refractory borderline patients. J Clin Psychopharmacol. 1991; 11:116-120. Google Scholar79. Burton TM. Medical flap: anti-depression drug of Eli Lilly loses sales after attack by sect. Wall Street Journal. Friday, April 19,1991. Google Scholar80. Grinfeld MJ. Jury finds Prozac did not cause violence. Psychiatric Times. February 1995:33. Google Scholar81. Teicher MH, Glod C, Cole JO. Emergence of intense suicidal preoccupation during fluoxetine treatment. Am J Psychiatry. 1990; 147:207-210. Google Scholar82. Troisi A, Vicario E, Nuccetelli F, Ciani N, Pasini A. Effects of fluoxetine on aggressive behavior of adult inpatients with mental retardation and epilepsy. Pharmacopsychiatry. 1995; 28:73-76. Google Scholar83. Beasley CM, Potvin JH, Masica DN, Wheadon DE, Dornseif BE, Genduso LA. Fluoxetine: no association with suicidality in obsessive-compulsive disorder. J Affect Disord. 1992; 24:1-10. Google Scholar84. Tollefson GD, Rampey AH, Beasley CM, Enas GG, Potvin JH. Absence of a relationship between adverse events and suicidality during pharmacotherapy for depression. J Clin Psychopharmacol. 1994; 14:163-169. Google Scholar85. Heilgenstein JH, Beasley CM, Potvin JH. Fluoxetine not associated with increased aggression in controlled clinical trials. Int Clin Psychopharmacol. 1993; 8:277-280. Google Scholar86. Mann JJ, Kapur S. The emergence of suicidal ideation and behavior during antidepressant pharmacotherapy. Arch Gen Psychiatry. 1991; 48:1027-1033. Google Scholar87. Ratey JJ, Sovner R1 Mikkelsen E, et al. Buspirone therapy for maladaptive behavior and anxiety in developmentally disabled persons. J Clin Psychiatry. 1989; 50:382384. Google Scholar88. Ratey J, Sovner R, Parks A, et al. Buspirone treatment of aggression and anxiety in mentally retarded patients: a multiple-baseline, placebo lead-in study. J Clin Psychiatry. 1991; 52:159-162. Google Scholar89. Gedye A. Buspirone alone or with serotonergic diet reduced aggression in a developmentally disabled adult. Biol Psychiatry. 1991; 30:88-91. Google Scholar90. Quiason N, Ward D, Kitchen T. Buspirone for aggression. J Am Acad Child Adolesc Psychiatry. 1991; 30:1026. Letter. Google Scholar91. Levine AM. Buspirone and agitation in head injury. Brain Inj. 1988; 2:165-167. Google Scholar92. Bioulac B, Benezech M, Renaud B, et al. Serotonergic dysfunction in the 47,XYY syndrome. Biol Psychiatry. 1980; 15:917-923. Google Scholar93. Morand C, Young SN, Ervin FR. Clinical response of aggressive schizophrenics to oral tryptophan. Biol Psychiatry. 1983; 18:575-578. Google Scholar94. Volavka J, Crowner M, Brizer D, et al. Tryptophan treatment of aggressive psychiatric inpatients. Biol Psychiatry. 1990; 28:728-732. Google Scholar95. Vartiainen H, Tiihonen J, Putkonen A, Virkkunen M, Hakola P, Lehto H. Citalopram, a selective serotonin reuptake inhibitor, in the treatment of aggression in schizophrenia. Acta Psychiatr Scand. 1995; 91:348-351. Google Scholar96. Rasmussen DL, Olivier B, Raghoebar M, Mos J. Possible clinical applications of sereníes and some implications of their preclinical profile for their clinical use in psychiatric disorders. Drug Metabolism Drug Interactions. 1990; 8:159-186. Google Scholar97. Tiihonen J, Hakola P, Paanila J, Turtiainen M, Eltoprazine for aggression in schizophrenia and mental retardation. Lancet. 1993; 341:307. Google Scholar Previous article FiguresReferencesRelatedDetails Request Permissions InformationCopyright 2013, SLACK IncorporatedPDF download
Referência(s)